Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
PXMD Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: August 02, 2024
Report Source: 2024 1st Quarter Report
Kuvatris Therapeutics Inc. Stock Analysis PXMD
United States Health Care Nano Cap Report: PaxMedica, Inc. is a clinical stage biopharmaceutical company. The company is headquartered in Tarrytown, New York and currently employs 6 full-time employees. The company went IPO on 2022-08-19. The company is focusing on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms, ranging from neurodevelopmental disorders, including autism spectrum disorder (ASD), to neurodegenerative disorders, such as Fragile X Tremor Ataxia Syndrome (FXTAS) and post-viral Myalgic Encephalomyelitis/Chronic c Syndrome (ME/CFS), a debilitating physical and cognitive disorder believed to be viral in origin and with rising incidence globally due to the long-term effects of SARS-CoV-2 (COVID-19). Its lead program, PAX-101 is an intravenous formulation of suramin in the treatment of ASD and the advancement of the clinical understanding of using that agent against other disorders: fragile X syndrome (FXS), FXTAS, ME/CFS and Long COVID-19 Syndrome (LCS), a clinical diagnosis in individuals who have been previously infected with COVID-19.
Read More Kuvatris Therapeutics Inc (PXMD) Chart
Key Statistics of Kuvatris Therapeutics Inc (PXMD)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
1998.00P/E Ratio (TTM)
-52 Week Range
Market Cap
63.13KAvg. Volume
5906.27Dividend Yield
-Financial Metrics & Statements of Kuvatris Therapeutics Inc (PXMD)
FAQ's for Kuvatris Therapeutics Inc (PXMD)
- According to Musaffa’s Shariah screening methodology, Kuvatris Therapeutics Inc (PXMD) is currently classified as NOT HALAL as of August 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Kuvatris Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Kuvatris Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Kuvatris Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Kuvatris Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Kuvatris Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.